HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NPA Submits Wish List For Reducing FDA Regulatory Burdens Per Trump Order

This article was originally published in The Rose Sheet

Executive Summary

FDA’s NDI notification draft guidance should be rewritten and its Nutrition Facts and Supplement Facts Final Rule delayed, the Natural Products Association says in comments submitted to the agency in response to President Trump’s executive order aimed at cutting down on burdensome regulations.

You may also be interested in...

Proposed Tariffs Threaten Ingredient Supply Chain For US Supplement Firms

NPA sounds alarm on Trump administration tariffs on $200bn in Chinese goods scheduled for October. In letter US Trade Representative, NPA President and CEO Daniel Fabricant asks the agency to exempt 57 items from the Harmonized Tariff Schedule that would impact hundreds of dietary ingredients.

FDA Guidance Adds 8 Non-Digestible Carbohydrates As Dietary Fibers

Guidance FDA published June 12 identifies isolated or synthetic non-digestible carbohydrates that can be included in the dietary fiber totals on Nutrition Fact labels for food products and on Supplement Fact labels for vitamins and supplements

NPA Members Get Regulatory Tools In Website Update, Awards At Big Natural

Natural Products Association modernizes its website with numerous databases to conduct regulatory and ingredient data searches and also offers education resources for its members. The association also honors industry advocates and celebrates 10 years of its Natural Seal Program.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts